APA (7th ed.) Citation

Conteduca, V., Wetterskog, D., Sharabiani, M. T. A., Grande, E., Fernandez-Perez, M. P., Jayaram, A., . . . Climent, M. A. (2017). Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: A multi-institution correlative biomarker study. Annals of Oncology, 28(7), 1508. https://doi.org/10.1093/annonc/mdx155

Chicago Style (17th ed.) Citation

Conteduca, V., et al. "Androgen Receptor Gene Status in Plasma DNA Associates with Worse Outcome on Enzalutamide or Abiraterone for Castration-resistant Prostate Cancer: A Multi-institution Correlative Biomarker Study." Annals of Oncology 28, no. 7 (2017): 1508. https://doi.org/10.1093/annonc/mdx155.

MLA (9th ed.) Citation

Conteduca, V., et al. "Androgen Receptor Gene Status in Plasma DNA Associates with Worse Outcome on Enzalutamide or Abiraterone for Castration-resistant Prostate Cancer: A Multi-institution Correlative Biomarker Study." Annals of Oncology, vol. 28, no. 7, 2017, p. 1508, https://doi.org/10.1093/annonc/mdx155.